Therapeutic Potential of SH2 Domain-Containing Inositol-5′-Phosphatase 1 (SHIP1) and SHIP2 Inhibition in Cancer
Gwenny M. Fuhler(Erasmus MC), William G. Kerr(Amicus Therapeutics (United Kingdom))
Cited by 112
Related Papers
SHIP1 Inhibition Increases Immunoregulatory Capacity and Triggers Apoptosis of Hematopoietic Cancer Cells
|The Journal of Immunology|2010|142
Autophagy mediates ER stress and inflammation in <i>Helicobacter pylori</i> -related gastric cancer
|Gut Microbes|2021|65